RU2010141560A - Лечение офтальмологических заболеваний - Google Patents

Лечение офтальмологических заболеваний Download PDF

Info

Publication number
RU2010141560A
RU2010141560A RU2010141560/15A RU2010141560A RU2010141560A RU 2010141560 A RU2010141560 A RU 2010141560A RU 2010141560/15 A RU2010141560/15 A RU 2010141560/15A RU 2010141560 A RU2010141560 A RU 2010141560A RU 2010141560 A RU2010141560 A RU 2010141560A
Authority
RU
Russia
Prior art keywords
diabetic
ophthalmic
age
ophthalmic disorder
formula
Prior art date
Application number
RU2010141560/15A
Other languages
English (en)
Russian (ru)
Inventor
Томас ОЛИДЖИНО (US)
Томас ОЛИДЖИНО
Чанг ХАН (US)
Чанг ХАН
Тимоти А. ГИЛЛЕСПИ (US)
Тимоти А. ГИЛЛЕСПИ
Рамалинга ДХАРАНИПРАГАДА (US)
Рамалинга ДХАРАНИПРАГАДА
Эллен МАЦКИН (US)
Эллен МАЦКИН
Original Assignee
Санофи-Авентис (Fr)
Санофи-Авентис
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи-Авентис (Fr), Санофи-Авентис filed Critical Санофи-Авентис (Fr)
Publication of RU2010141560A publication Critical patent/RU2010141560A/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
RU2010141560/15A 2008-03-10 2009-03-05 Лечение офтальмологических заболеваний RU2010141560A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3507308P 2008-03-10 2008-03-10
US61/035,073 2008-03-10

Publications (1)

Publication Number Publication Date
RU2010141560A true RU2010141560A (ru) 2012-04-20

Family

ID=40583469

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010141560/15A RU2010141560A (ru) 2008-03-10 2009-03-05 Лечение офтальмологических заболеваний

Country Status (22)

Country Link
EP (1) EP2285378A1 (ko)
JP (1) JP2011513488A (ko)
KR (1) KR20110009084A (ko)
CN (1) CN101965188A (ko)
AR (1) AR070975A1 (ko)
AU (1) AU2009223501A1 (ko)
BR (1) BRPI0909659A2 (ko)
CA (1) CA2717991A1 (ko)
CL (1) CL2009000551A1 (ko)
CO (1) CO6290691A2 (ko)
CR (1) CR11644A (ko)
DO (1) DOP2010000266A (ko)
IL (1) IL207906A0 (ko)
MA (1) MA32211B1 (ko)
MX (1) MX2010008308A (ko)
NI (1) NI201000131A (ko)
NZ (1) NZ587906A (ko)
RU (1) RU2010141560A (ko)
SV (1) SV2010003658A (ko)
TW (1) TW200950784A (ko)
WO (1) WO2009114373A1 (ko)
ZA (1) ZA201005337B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR074776A1 (es) 2008-12-18 2011-02-09 Sanofi Aventis Metodo para tratar la degeneracion macular; modulando el sistema inmunitario del paciente
EP2441755A1 (en) 2010-09-30 2012-04-18 Almirall, S.A. Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
EP2489663A1 (en) 2011-02-16 2012-08-22 Almirall, S.A. Compounds as syk kinase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ3377A1 (fr) * 1999-12-24 2001-07-05 Aventis Pharma Ltd Azaindoles
JP2003523390A (ja) * 2000-02-25 2003-08-05 メルク エンド カムパニー インコーポレーテッド チロシンキナーゼ阻害薬
US7563787B2 (en) * 2005-09-30 2009-07-21 Miikana Therapeutics, Inc. Substituted pyrazole compounds
CL2007002617A1 (es) * 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.

Also Published As

Publication number Publication date
JP2011513488A (ja) 2011-04-28
CA2717991A1 (en) 2009-09-17
NI201000131A (es) 2011-09-29
SV2010003658A (es) 2011-01-31
CR11644A (es) 2010-11-22
BRPI0909659A2 (pt) 2015-09-22
WO2009114373A1 (en) 2009-09-17
AR070975A1 (es) 2010-05-19
CN101965188A (zh) 2011-02-02
TW200950784A (en) 2009-12-16
IL207906A0 (en) 2010-12-30
NZ587906A (en) 2011-12-22
AU2009223501A1 (en) 2009-09-17
ZA201005337B (en) 2011-04-28
MX2010008308A (es) 2010-08-11
KR20110009084A (ko) 2011-01-27
EP2285378A1 (en) 2011-02-23
MA32211B1 (fr) 2011-04-01
DOP2010000266A (es) 2010-09-30
CO6290691A2 (es) 2011-06-20
CL2009000551A1 (es) 2009-08-21

Similar Documents

Publication Publication Date Title
JP2019196381A (ja) 軸索再生および神経機能を促進するための方法および組成物
RU2018110647A (ru) Арильные, гетероарильные и гетероциклические соединения для лечения заболеваний
UA107578C2 (uk) Комбінована терапія при лікуванні діабету
HRP20100559T1 (hr) Liječenje neovaskularnih poremećaja oka, poput makularne degeneracije, angioidnih strija, uveitisa i edema makule
RU2014135436A (ru) Комбинация ингибитора rtk с антиэстрогеном и ее применение для лечения рака
JP2008540528A5 (ko)
BR112016015763B8 (pt) preparação farmacêutica incluindo composto de ácido piridilaminocético, e, uso da mesma
JP2017518360A5 (ko)
AR062395A1 (es) Uso de derivados del 2.5-dihidroxibenceno para el tratamiento de enfermedades oculares
RU2014144254A (ru) Комбинированные продукты, содержащие ингибиторы тирозинкиназ, и их применение
WO2018005794A3 (en) Novel non-systemic tgr5 agonists
WO2018005801A3 (en) Novel non-systemic tgr5 agonists
RU2010141560A (ru) Лечение офтальмологических заболеваний
RU2006124557A (ru) Композиции и способы введения средств, связывающих тубулин, для лечения глазных заболеваний
TW200719893A (en) Dosage forms, pharmaceutical compositions and methods for sub-tenon delivery
KR20120112162A (ko) 황반변성 예방 또는 치료용 약학 조성물
RU2018103031A (ru) Производные пиридин-3-ил уксусной кислоты в качестве ингибиторов репликации вируса иммунодефицита человека
MX2022005639A (es) Compuestos inhibidores de pde-5 y/o pde-6 donadores de oxido de nitrogeno.
US10537563B2 (en) Methods for treating ocular disease using inhibitors of CSF-1R
RU2015157534A (ru) Препарат для лечения костных наростов, головных болей и болей в сердце
CA2468811A1 (en) Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders
FI3519050T3 (fi) Koostumuksia silmätautien hoitamiseksi
RU2011127128A (ru) Лечение гломерулонефрита
RU2017102975A (ru) Производные индолинона, обладающих свойствами лигандов мелатонинового рецептора и их применение
RU2018102554A (ru) Производные пиридин-3-ил уксусной кислоты в качестве ингибиторов репликации вируса иммунодефицита человека